Feasibility of a Molecular Characterisation Approach to Treatment

Study ID
NCT02112357

Study type
Observational

Study phase

Study status
Unknown status

Trial Acronym

FOrMAT

Trial Summary

This study will assess the feasibility of sequencing locally advanced/metastatic gastrointestinal cancers in real-time to enable future treatment stratification by molecular characteristics. Targeted next generation sequencing of a panel of genes will be performed on tumour specimens and results will be discussed at a Sequencing Tumour Board to establish if a patient is potentially suitable for a targeted therapy.

More informations

Trial Starting Date

Feb 28,2014

Requirements

Gender All
Minimum age 18 Years
Maximum age N/A

Enrollement Limit

200